Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Increased ALK1 copy number and renal cell carcinoma-a case report.

Ryan C, Mayer N, Cunningham J, Hislop G, Pratt N, Fleming S.

Virchows Arch. 2014 Feb;464(2):241-5. doi: 10.1007/s00428-013-1520-3. Epub 2013 Dec 7.

PMID:
24318419
2.

ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.

Sukov WR, Hodge JC, Lohse CM, Akre MK, Leibovich BC, Thompson RH, Cheville JC.

Mod Pathol. 2012 Nov;25(11):1516-25. doi: 10.1038/modpathol.2012.107. Epub 2012 Jun 29.

3.

Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum.

Debelenko LV, Raimondi SC, Daw N, Shivakumar BR, Huang D, Nelson M, Bridge JA.

Mod Pathol. 2011 Mar;24(3):430-42. doi: 10.1038/modpathol.2010.213. Epub 2010 Nov 12.

4.

ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult.

Jeanneau M, Gregoire V, Desplechain C, Escande F, Tica DP, Aubert S, Leroy X.

Pathol Res Pract. 2016 Nov;212(11):1064-1066. doi: 10.1016/j.prp.2016.07.015. Epub 2016 Aug 2.

PMID:
27554841
5.

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.

Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.

Am J Surg Pathol. 2013 Jun;37(6):804-15. doi: 10.1097/PAS.0b013e31827e17cb.

PMID:
23598965
6.

EGF-r gene copy number changes in renal cell carcinoma detected by fluorescence in situ hybridization.

Moch H, Sauter G, Gasser TC, Bubendorf L, Richter J, Presti JC Jr, Waldman FM, Mihatsch MJ.

J Pathol. 1998 Apr;184(4):424-9.

PMID:
9664910
7.

Two Cases of Renal Cell Carcinoma Harboring a Novel STRN-ALK Fusion Gene.

Kusano H, Togashi Y, Akiba J, Moriya F, Baba K, Matsuzaki N, Yuba Y, Shiraishi Y, Kanamaru H, Kuroda N, Sakata S, Takeuchi K, Yano H.

Am J Surg Pathol. 2016 Jun;40(6):761-9. doi: 10.1097/PAS.0000000000000610.

PMID:
26848800
8.

Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases.

Hodge JC, Pearce KE, Wang X, Wiktor AE, Oliveira AM, Greipp PT.

Mod Pathol. 2014 Jan;27(1):113-27. doi: 10.1038/modpathol.2013.83. Epub 2013 Jul 5.

9.

Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.

Zhou M, Yang XJ, Lopez JI, Shah RB, Hes O, Shen SS, Li R, Yang Y, Lin F, Elson P, Sercia L, Magi-Galluzzi C, Tubbs R.

Am J Surg Pathol. 2009 Dec;33(12):1840-9. doi: 10.1097/PAS.0b013e3181be22d1.

PMID:
19898225
10.

[The translocation carcinoma: A pediatric renal tumor also in adults].

Bruder E, Moch H.

Pathologe. 2016 Mar;37(2):159-65. doi: 10.1007/s00292-016-0151-2. Review. German.

11.

Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service.

Green WM, Yonescu R, Morsberger L, Morris K, Netto GJ, Epstein JI, Illei PB, Allaf M, Ladanyi M, Griffin CA, Argani P.

Am J Surg Pathol. 2013 Aug;37(8):1150-63. doi: 10.1097/PAS.0b013e31828a69ae.

PMID:
23715164
12.

Renal cell carcinoma with mixed features of papillary and clear cell cytomorphology: a fluorescent in situ hybridization study.

Mai KT, Faraji H, Desantis D, Robertson SJ, Belanger EC, Levac J.

Virchows Arch. 2010 Jan;456(1):77-84. doi: 10.1007/s00428-009-0871-2. Epub 2009 Dec 22.

PMID:
20033232
13.

Molecular-genetic analysis is essential for accurate classification of renal carcinoma resembling Xp11.2 translocation carcinoma.

Hayes M, Peckova K, Martinek P, Hora M, Kalusova K, Straka L, Daum O, Kokoskova B, Rotterova P, Pivovarčikova K, Branzovsky J, Dubova M, Vesela P, Michal M, Hes O.

Virchows Arch. 2015 Mar;466(3):313-22. doi: 10.1007/s00428-014-1702-7. Epub 2014 Dec 28.

PMID:
25544614
14.

Oncocytic papillary renal cell carcinoma: a clinicopathological study emphasizing distinct morphology, extended immunohistochemical profile and cytogenetic features.

Xia QY, Rao Q, Shen Q, Shi SS, Li L, Liu B, Zhang J, Wang YF, Shi QL, Wang JD, Ma HH, Lu ZF, Yu B, Zhang RS, Zhou XJ.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1392-9. Print 2013.

15.

Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.

Williamson SR, Gupta NS, Eble JN, Rogers CG, Michalowski S, Zhang S, Wang M, Grignon DJ, Cheng L.

Am J Surg Pathol. 2015 Nov;39(11):1502-10. doi: 10.1097/PAS.0000000000000514.

PMID:
26457355
16.

Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.

Tran T, Jones CL, Williamson SR, Eble JN, Grignon DJ, Zhang S, Wang M, Baldridge LA, Wang L, Montironi R, Scarpelli M, Tan PH, Simper NB, Comperat E, Cheng L.

Histopathology. 2016 May;68(6):850-7. doi: 10.1111/his.12840. Epub 2015 Oct 21.

PMID:
26310887
17.

A case of bilateral renal cell carcinoma associated with long-term dialysis showing false-positive immunoreactivity for TFE3 as Xp11 translocation renal cell carcinoma.

Kurisaki-Arakawa A, Saito T, Takahashi M, Mitani K, Fukumura Y, Nagashima Y, Argani P, Yao T.

Int J Clin Exp Pathol. 2013 Oct 15;6(11):2585-90. eCollection 2013.

18.

Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.

Jones TD, Eble JN, Wang M, MacLennan GT, Delahunt B, Brunelli M, Martignoni G, Lopez-Beltran A, Bonsib SM, Ulbright TM, Zhang S, Nigro K, Cheng L.

Clin Cancer Res. 2005 Oct 15;11(20):7226-33.

19.

VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?

Smith NE, Deyrup AT, Mariño-Enriquez A, Fletcher JA, Bridge JA, Illei PB, Netto GJ, Argani P.

Am J Surg Pathol. 2014 Jun;38(6):858-63. doi: 10.1097/PAS.0000000000000179.

20.

Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases.

Skenderi F, Ulamec M, Vanecek T, Martinek P, Alaghehbandan R, Foix MP, Babankova I, Montiel DP, Alvarado-Cabrero I, Svajdler M, Dubinský P, Cempirkova D, Pavlovsky M, Vranic S, Daum O, Ondic O, Pivovarcikova K, Michalova K, Hora M, Rotterova P, Stehlikova A, Dusek M, Michal M, Hes O.

Ann Diagn Pathol. 2017 Apr;27:48-56. doi: 10.1016/j.anndiagpath.2017.01.005. Epub 2017 Jan 19.

PMID:
28325361

Supplemental Content

Support Center